Related Experiment Videos
Prediction of visual field progression in glaucoma
Kouros Nouri-Mahdavi1, Douglas Hoffman, Douglas Gaasterland
1Glaucoma Division, Jules Stein Eye Institute, University of California Los Angeles, 100 Stein Plaza, Los Angeles, CA 90095, USA.
Investigative Ophthalmology & Visual Science
|November 24, 2004
Summary
The visual field (VF) sum of slopes accurately predicts future glaucoma progression. This metric, combined with patient age, aids in estimating the likelihood of worsening VF loss in glaucoma patients.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Visual Field Analysis
Background:
- Glaucoma is a leading cause of irreversible blindness.
- Early detection and prediction of visual field (VF) progression are crucial for managing glaucoma.
- Existing methods for predicting VF progression require refinement.
Purpose of the Study:
- To determine the probability of future glaucomatous visual field (VF) progression.
- To evaluate the utility of clinical and perimetric data in predicting glaucoma progression.
- To assess the predictive power of the sum of slopes index for VF worsening.
Main Methods:
- Analysis of 161 eyes from the Advanced Glaucoma Intervention Study (AGIS) with at least 8 years of follow-up.
- Point-wise linear regression (PLR) used to determine VF progression over 8 years.
- Calculation of the sum of slopes index from the first 4 years of VF data to quantify progression rate.
Main Results:
- 40% of eyes showed VF progression after 8 years.
- A more negative sum of slopes (faster deterioration) and older age at 4 years were significant predictors of progression (76% predictive power).
- The sum of slopes alone provided equivalent predictive accuracy for 8-year outcomes.
Conclusions:
- The VF sum of slopes is a clinically useful tool for estimating the probability of future VF worsening in glaucoma.
- Combining the sum of slopes with other clinical data can enhance prediction accuracy.
- This approach supports more effective clinical predictions and treatment decisions for glaucoma patients.